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Diabetic amyotrophy is a rare complication of diabetes mellitus at any age, but it
is almost unreported in the literature below the age of 30 years. We report the
case of a 16 year old boy who attempted suicide due to the symptoms of diabetic
amyotrophy.
CASE REPORT. A 16-year-old boy was admitted following an overdose of
48 tablets of diclofenac 100 mg, 20 tablets of codeine phosphate 30 mg and 40
tablets of paracetamol 500 mg. He was alert and felt well on admission. General
examination was normal. His serum paracetamol level on arrival was 34 mg/I,
which did not justify treatment with acetyl cysteine. Serum sodium, potassium
and urea were normal. He was treated conservatively and observed overnight.
On further questioning the patient revealed that the reason for his overdose was
increasing clumsiness in his legs over the preceding six months which had halted
a promising athletic career and had led tohim being the focusofteasing at school.
His home situation seemed to be supportive and caring, and no other cause for
his attempted suicide was apparent.
He admitted to polyuria and polydipsia associated with weight loss of approx-
imately 5 kg over the six months prior to admission. Detailed examination of his
central nervous system revealed normal cranial nerve function, with normal optic
fundi. A grade 2/5 weakness in his right extensor hallucis group of muscles was
present, but no obvious weakness of the quadriceps or psoas muscle groups was
detected, despite wasting of both thighs and calves. His gait was clumsy and
broad-based, with hyper-extension of both knees. He was unable to stand on
tiptoes. Tendon reflexes were absent in arms and legs, with downgoing plantar
responses. There was no sensory deficit or impairment of joint position sense.
His random plasma glucose was 33-1 mmol/l. His haemoglobin concentration,
white cell count, serum urea electrolytes and liver function tests were normal.
Serum thyroxine, thyroid stimulating hormone, vitamin B12 and folate,
complement, immunoglobulins and immune complexes were all normal. Serum
auto-antibody tests, rheumatoid factor and porphyrin levels were normal. His
serum aldolase was 3-5 iu/l (normal range 1-2 to 7-6) and creatine kinase
40 iu/l (less than 150). Radiograph of the lumbar spine was normal.
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The diagnosis of diabetes mellitus was confirmed by the hyperglycaemia, and
treatment was started with insulin. Within two weeks his plasma glucose levels
were well controlled and he was allowed home. He was reviewed two weeks,
six weeks, and four months later to assess the progress of both his diabetes
and his muscle weakness. Exercise tolerance, assessed at two weeks and at
four months by maximum running distance in ten minutes had increased from
760m to 1765m. By the end of four months the wasting of his legs noted on
admission had resolved (thigh measurements increased from 41 to 49 cms and
calf measurements from 15 to 25 cms), and his tendon reflexes had returned to
normal. His diabetic control was good with average plasma glucose throughout
the day 7-5 mmol/l and glycosylated haemoglobin (HbA1) 9*3% (normal
< 7-5%). He felt considerably better in himself and all depressive and suicidal
ideas had gone.
DISCUSSION
Diabetic amyotrophy is an unusual presentation of diabetes mellitus, as too is
attempted suicide. First described in 1890 by Bruns in Germany it was not until
1953 that Garland1 again brought the condition to the notice of contemporary
clinicians. Described as a disease associated with poor control of diabetes
mellitus2, 3 it usually presents with weakness and muscle wasting of the lower
limbs, often associated with pain, and usually without loss of touch or joint
position sense.2 It is more common in the older diabetic and we have been able to
find onlyone reportofa patient under the ageof33 yearsin the past seven years.3
The absence of pain in the legs does not fit with the more usual presentation of
the condition but there are examples in the literature of pain-free diabetic
amyotrophy.2'4 The involvement of the extensor hallucis group of muscles is of
interest as Garland described a similar distribution in three of his 12 cases.2 The
term diabetic proximal motor neuropathy is sometimes preferred but is less
appropriate in this case as there was no demonstrable proximal weakness. The
abnormal gait and hyper-extension of the knees would, however, indicate some
involvement of the quadriceps and psoas muscle groups.
The pathogenesis of diabetic amyotrophy remains obscure. Garland felt on the
basis of nerve conduction studies that the primary lesion was in the lumbar spinal
cord and he postulated a lower motor neurone neuropathy.1 It was noted that
as the diabetic control improved so also did the muscle weakness.2'3'4 This is
consistent with the metabolic theory, with accumulation of intraneuronal sorbitol
and depletion of myoinositol. This results in nerve dysfunction and damage.56,'7
These metabolic pathways are dependent on the enzyme aldose reductase, and
the dysfunction and biochemical abnormalities of diabetic neuropathy can be
improved by the administration of aldose reductase inhibitors.5'6 Diabetic neuro-
pathy is usually diffuse and symmetrical but there are often focal features,
particularly in diabetic amyotrophy. This suggests that microvascular disease
contributes to pathogenesis. The demonstration of resistance in a diabetic nerve
to the effects of ischaemia, possibly due to an adaptive process, is further
evidence of the vascular theory.7 The precise aetiology, however, remains
unclear, but a combination of factors is likely.
The differential diagnosis would include femoral neuritis, sciatica, carcinomatous
neuropathy, intra-pelvic neoplasm, motor neurone disease, thyrotoxicosis and
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Guillain-Barre syndrome. Electrophysiological studies and a lumbar puncture
would have helped to confirm the diagnosis, but we are satisfied that our investig-
ations, and the marked improvement with control of his diabetes, indicate that
the correct diagnosis of this case is diabetic amyotrophy.
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